These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1748302)

  • 61. RET rearrangements in radiation-induced papillary thyroid carcinomas: high prevalence of topoisomerase I sites at breakpoints and microhomology-mediated end joining in ELE1 and RET chimeric genes.
    Klugbauer S; Pfeiffer P; Gassenhuber H; Beimfohr C; Rabes HM
    Genomics; 2001 Apr; 73(2):149-60. PubMed ID: 11318605
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mechanism of Ret activation by a mutation at aspartic acid 631 identified in sporadic pheochromocytoma.
    Asai N; Iwashita T; Murakami H; Takanari H; Ohmori K; Ichihara M; Takahashi M
    Biochem Biophys Res Commun; 1999 Feb; 255(3):587-90. PubMed ID: 10049754
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tyrosine kinase activity of the ret proto-oncogene products in vitro.
    Miyazaki K; Asai N; Iwashita T; Taniguchi M; Isomura T; Funahashi H; Takagi H; Matsuyama M; Takahashi M
    Biochem Biophys Res Commun; 1993 Jun; 193(2):565-70. PubMed ID: 7685595
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B.
    Santoro M; Carlomagno F; Romano A; Bottaro DP; Dathan NA; Grieco M; Fusco A; Vecchio G; Matoskova B; Kraus MH
    Science; 1995 Jan; 267(5196):381-3. PubMed ID: 7824936
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Low rate of ret proto-oncogene activation (PTC/retTPC) in papillary thyroid carcinomas from Saudi Arabia.
    Zou M; Shi Y; Farid NR
    Cancer; 1994 Jan; 73(1):176-80. PubMed ID: 8275421
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In vitro irradiation is able to cause RET oncogene rearrangement.
    Ito T; Seyama T; Iwamoto KS; Hayashi T; Mizuno T; Tsuyama N; Dohi K; Nakamura N; Akiyama M
    Cancer Res; 1993 Jul; 53(13):2940-3. PubMed ID: 8319199
    [TBL] [Abstract][Full Text] [Related]  

  • 67. RET proto-oncogene mutations and rearrangements in endocrine diseases.
    Lloyd RV
    Am J Pathol; 1995 Dec; 147(6):1539-44. PubMed ID: 7495277
    [No Abstract]   [Full Text] [Related]  

  • 68. Loss of function effect of RET mutations causing Hirschsprung disease.
    Pasini B; Borrello MG; Greco A; Bongarzone I; Luo Y; Mondellini P; Alberti L; Miranda C; Arighi E; Bocciardi R
    Nat Genet; 1995 May; 10(1):35-40. PubMed ID: 7647787
    [TBL] [Abstract][Full Text] [Related]  

  • 69. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.
    Greco A; Pierotti MA; Bongarzone I; Pagliardini S; Lanzi C; Della Porta G
    Oncogene; 1992 Feb; 7(2):237-42. PubMed ID: 1532241
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Novel human oncogene lbc detected by transfection with distinct homology regions to signal transduction products.
    Toksoz D; Williams DA
    Oncogene; 1994 Feb; 9(2):621-8. PubMed ID: 8290273
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Activation of the ret-II oncogene without a sequence encoding a transmembrane domain and transforming activity of two ret-II oncogene products differing in carboxy-termini due to alternative splicing.
    Ishizaka Y; Ochiai M; Tahira T; Sugimura T; Nagao M
    Oncogene; 1989 Jun; 4(6):789-94. PubMed ID: 2734021
    [TBL] [Abstract][Full Text] [Related]  

  • 72. ret transforming gene encodes a fusion protein homologous to tyrosine kinases.
    Takahashi M; Cooper GM
    Mol Cell Biol; 1987 Apr; 7(4):1378-85. PubMed ID: 3037315
    [TBL] [Abstract][Full Text] [Related]  

  • 73. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident.
    Klugbauer S; Lengfelder E; Demidchik EP; Rabes HM
    Oncogene; 1995 Dec; 11(12):2459-67. PubMed ID: 8545102
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The role of non-ras transforming genes in chemical carcinogenesis.
    Cooper CS
    Environ Health Perspect; 1991 Jun; 93():33-40. PubMed ID: 1685444
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Translocation t(10;14)(q11.2:q22.1) fusing the kinetin to the RET gene creates a novel rearranged form (PTC8) of the RET proto-oncogene in radiation-induced childhood papillary thyroid carcinoma.
    Salassidis K; Bruch J; Zitzelsberger H; Lengfelder E; Kellerer AM; Bauchinger M
    Cancer Res; 2000 Jun; 60(11):2786-9. PubMed ID: 10850414
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Various mechanisms cause RET-mediated signaling defects in Hirschsprung's disease.
    Pelet A; Geneste O; Edery P; Pasini A; Chappuis S; Atti T; Munnich A; Lenoir G; Lyonnet S; Billaud M
    J Clin Invest; 1998 Mar; 101(6):1415-23. PubMed ID: 9502784
    [TBL] [Abstract][Full Text] [Related]  

  • 77. RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer.
    Blaugrund JE; Johns MM; Eby YJ; Ball DW; Baylin SB; Hruban RH; Sidransky D
    Hum Mol Genet; 1994 Oct; 3(10):1895-7. PubMed ID: 7849720
    [No Abstract]   [Full Text] [Related]  

  • 78. Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer.
    Fusco A; Chiappetta G; Hui P; Garcia-Rostan G; Golden L; Kinder BK; Dillon DA; Giuliano A; Cirafici AM; Santoro M; Rosai J; Tallini G
    Am J Pathol; 2002 Jun; 160(6):2157-67. PubMed ID: 12057919
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Absence of RET proto-oncogene point mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid gland.
    Padberg BC; Schröder S; Jochum W; Kastendieck H; Roth J; Heitz PU; Komminoth P
    Am J Pathol; 1995 Dec; 147(6):1600-7. PubMed ID: 7495285
    [TBL] [Abstract][Full Text] [Related]  

  • 80. DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the ret proto-oncogene.
    Ceccherini I; Hofstra RM; Luo Y; Stulp RP; Barone V; Stelwagen T; Bocciardi R; Nijveen H; Bolino A; Seri M
    Oncogene; 1994 Oct; 9(10):3025-9. PubMed ID: 8084609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.